Molecular genetic of the remethylation of homocysteine;Genetique moleculaire de la remethylation de l'homocysteine

Annales de Biologie Clinique

Volumn 57, Issue 1, 1999, Pages 37-42

  Chango, A ^a   Parrot Roulaud, F ^a   Nicolas, J P ^a  

^a NONE

Author keywords

Folate; Homocysteine; Methionine synthase; Methionine synthase reductase; Methylenetetrahydrofolate dehydrogenase; Methylenetetrahydrofolate reductase; Neural tube defect

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; 5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; METHIONINE SYNTHASE REDUCTASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASE;

AMINO ACID BLOOD LEVEL; DIET RESTRICTION; HUMAN; HYPERHOMOCYSTEINEMIA; MATERNAL PLASMA; METHYLATION; MOLECULAR GENETICS; NEURAL TUBE DEFECT; NUTRITION; PATHOPHYSIOLOGY; REVIEW; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETICS; METABOLISM;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); 5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; FERREDOXIN-NADP REDUCTASE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; METHYLATION; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP); METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEURAL TUBE DEFECTS; OXIDOREDUCTASES; POLYMORPHISM, GENETIC;

EID: 0033006092     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. McCully KS. Vascular pathology of homocysteinemia : implication for the pathogenesis of arteriosclerosis. Am J Pathol 1969 ; 59 : 111-28.
2. Carson NAJ, Neill DW. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Dis Child 1962 ; 37 : 505-13.
3. Boushey J, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for cardiovascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995 ; 274 : 1049-57.
4. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Eng J Med 1998 ; 338 : 1042-50.
5. Mills JL, McParthin JM, Kirke PN, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995 ; 345 : 114-51.
6. Goddijn-Wessel TAW, Wouters MGAJ, van der Molen EF, et al. Hyperhomocysteinemia : a risk factor for placental abruption or infarction. Eur J Obstet Gynaecol 1996 ; 66 : 23-9.
7. Quere I, Bellet H, Hoffet M, Janhon C, Mares P, Gris JC. A woman with five consecutive fetal deaths : case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages. Fertil Steril 1998 ; 69 : 152-4.
8. Eskes TKAB. 1997. Folates and the fetus. Eur J Obstet Gynecol 71 : 105-11.
9. Smith AD, Clarke R, Jobst KA, Refsum H, Sutton L, Reland PM. Hyperhomocysteinemia : an independent risk factor for histopathologically-confirmed Alzheimer's disease. Neth J Med 1998 ; 52 : S16.
10. Regland B, Andersson M, Abrahamsson L, Bagby J, Dyrehag LE, Gottfries CG. Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome. Scand J Rheumat 1997 ; 26 : 301-7.
11. Ueland PM, Resfsum H. Plasma homocysteine, a risk factor for vascular disease : plasma levels in health disease and drug therapy. J Lab Clin Med 1989 ; 114 : 473-501.
12. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen R. Total homocysteine in plasma or serum : methods and chemical application. Clin Chem 1993 ; 39 : 1764-79.
13. Stabler SP, Marcell PD, Powell ER, Allen RH, Savage G, Lindenbaum J. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 1988 ; 81 : 466-74.
14. Frantzen F, Ludvig Faaren A, Alfheim I, Nordhei KA. Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chemistry 1998 ; 44 : 311-6.
15. Sardharwalla IB, Fowler B, Robin AJ, Komrower GM. Detection of heterozygotes for homocystinuria. Arch Dis Child 1974 ; 49 : 553-9.
16. Chango A, Perrin MO, Tronel H, Nicolas JP. Aspects nutritionnels et biochimiques du métabolisme de l'homocystéine. Nutr Clin Métabol 1997 ; 11 : 201-11.
17. Ueland PM, Refsum H, Brattström L. Plasma homocysteine and cardiovascular disease. In : Atherosclerotic cardiovascular disease, hemostasis, and endothelial function. Francis RB, Dekker Jr. M Eds. New York. 1994 ; 183-235.
18. Rees MM, Rodgers GM. Homocysteinemia association of metabolic disorder with vascular disease and thrombosis. Thromb Research 1993 ; 71 : 337-59.
19. Rosenblatt DS, Richard WE. MTHFR in cultured human cells. I. Growth and metabolic studies. Pediat Res 1977 ; 1137-40.
20. Kang SS, Zhou J, Wong PWK, Kowalisyn J, Strokosch G. Intermediate homocysteinemia : a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988 ; 43 : 414-21.
21. Weissbach H, Peterkofsky A, Redfield BG, Dickerman H. Studies on the terminal reaction in biosynthesis of methionine. J Biol Chem 1963 ; 238 : 3318-24.
22. Gulati S, Chen ZQ, Brody LC, Rosenblatt DS, Banerjee R. Defects in auxiliary redox proteins lead to functional methionine synthase deficiency. J Biol Chem 1997 ; 272 : 19171-5.
23. Watkins D, Rosenblalt DS. Genetic heterogeneity among patients with methylcobalamin deficiency : definition of two complementation groups, cblE and cblG. J Clin Invest 1988 ; 81 : 1690-4.
24. Watkins D, Rosenblatt DS. Functional methionine synthase deficiency (cblE and cblG) : clinical and biochemical heterogeneity. Am J Med Genet 1989 ; 34 : 427-34.
25. Leclerc D, Wilson A, Dumas R, et al. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA 1998 ; 95 : 3059-64.
26. MRC Vitamin study Research Group. Prevention of neural tube defects : results of the Medical Research Council Vitamin Study. Lancet 1991 ; 338 : 131-7.
27. Weitkamp LR, Tackels DC, Hunter AGW, Holmes LB, Schwartz CE. Heterozygote advantage of the MTHFR gene in patients with neural-tube defect and their relatives. Lancet 1998 ; 351 : 1554-6.
28. Ludwig ML, Matthews RG. Structure-based perspectives on B-12-dependent enzymes. Annu Rev Biochem 1997 ; 66 : 269-313.
29. Goyette P, Summer SJ, Milos R, Duncan AMV, Rosenblatt DS. Human methylenetetrahydrofolate reductase : isolation of cDNA mapping and mutation identification. Nature Genet 1994 ; 7 : 195-200. Errata. Nature Genet 1994 ; 7 : 551.
30. Frosst F, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease : a common mutation MTHFR. Nature Genet 1995 ; 10 : 111-3.
31. Schneider JA, Rees DC, Liu YT, Clegg JB. Wordwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum-Genet 1998 ; 62 : 1258-60.
32. Kluijtmans LAJ, van den Heuvel LPWJ, Boers GHJ, et al. Molecular genetic analysis in mild hyperhomocysteinemia : a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996 ; 58 : 35-41.
33. Christensen B, Frosst P, Lussier-Cacan S, et al. Correlation of a common mutation in the methylenetetrahydrofolate reductase (MTHFR) gene with plasma homocysteine in patients with premature coronary artery disease. After Thromb Vasc Biol 1997 ; 17 : 569-73.
34. Kirke PN, Mills JL, Whitehead AS, Molloy A, Scott JM. Methylenetetrahydrofolate reductase mutation and neural tube defects. Lancet 1996 ; 348 : 1037-8.
35. Van der Put NM, Steegers-Theunissen RPM, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995 ; 346 : 1070-1.
36. Ma J, Stampfer MJ, Giovannucci E, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997 ; 57 : 1098-102.
37. Chen J, Giovannucci E, Kelsey K, et al. A Methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1997 ; 56 : 4862-4.
38. Van der Put NMJ, Gabreëls, Stevens EMB, et al. A second common mutation in the methylenetetrahydrofolate reductase gene : an additional risk factor for neural-tube defects ? Am J Hum Genet 1998 ; 62 : 1044-51.
39. Van der Put NMJ, Mol SG, Heil M, et al. SSCP analysis of the human methylenetetrahydrofolate dehydrogenase gene : relevance to neural tube defects. Neth J Med 1998 ; 52 : S30.
40. Li YN, Gulati S, Baker PJ, Brody LC, Banerjee R, Kruger WD. Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Molec Genet 1996 ; 5 : 1851-8.
41. Leclerc D, Campeau E, Goyette P, et al. Human methionine synthase : cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Molec Genet 1996 ; 5 : 1867-74.
42. Van der Put NMJ, van der Molen EF, Kluijtmans LAJ, et al. Sequence analysis of the coding region of human methionine synthase : Relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. Qjm Mon J Assoc Physician 1997 ; 90 : 511-7.
43. Rosenberg IH, Rosenberg LE. The implication of genetic diversity for nutrient requirements : the case of folate. Nutrition Review 1998 ; 56 : S47-53.
44. Dhondt JL. Les anomalies du métabolisme de l'homocystéine. Ann Biol Clin 1997 ; 55 : 647-8.